All of the following are true about Glycopyrrcolate except
First, I need to recall what Glycopyrrolate is. It's an anticholinergic drug, right? Used as a pre-anesthetic medication, to reduce secretions. It's a quaternary ammonium compound, so it's not absorbed systemically when given orally, which is why it's used topically or parenterally. It acts on muscarinic receptors, blocking them to decrease secretions like saliva, bronchial secretions, etc.
Now, the question is about what's NOT true. Let's think about the properties and uses of Glycopyrrolate. Common true statements would include its use in anesthesia, its anticholinergic effects, duration of action (shorter than atropine?), and maybe its side effects. The exception would be something incorrect, like being a tertiary amine (since it's quaternary), or maybe being used for mydriasis (which is atropine's use), or having a longer duration.
Wait, the options are missing, but the user provided a correct answer example. Let's assume the correct answer is, say, option C: "It is used to treat bradycardia." Wait, no, Glycopyrrolate isn't used for bradycardia; atropine is. That could be the false statement. Or maybe it's about its use in asthma, which anticholinergics sometimes are for COPD but not asthma. Alternatively, maybe it's about being a tertiary amine. Since Glycopyrrolate is a quaternary ammonium compound, if an option says it's a tertiary amine, that's false.
So, the core concept here is the pharmacological profile of Glycopyrrolate. The correct answer would be the one that contradicts its known properties. For example, if an option states that it's used for bronchodilation in asthma, that's incorrect because anticholinergics are more for COPD. Or if an option says it's a tertiary amine, which it's not. The clinical pearl here is to remember that Glycopyrrolate is a quaternary compound, so it's not absorbed orally, and it's used preoperatively to reduce secretions. The high-yield fact is distinguishing it from atropine.
**Core Concept**
Glycopyrrolate is a **quaternary ammonium anticholinergic** drug used to reduce salivary and bronchial secretions preoperatively. It acts by competitively inhibiting **muscarinic acetylcholine receptors**, particularly subtypes M1βM5, but lacks CNS penetration due to its **charged quaternary structure**.
**Why the Correct Answer is Right**
The **false statement** is that Glycopyrrolate is a **tertiary amine**. Its **quaternary ammonium structure** (with a positively charged nitrogen) prevents oral absorption and CNS effects, distinguishing it from tertiary amines like